Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19959008 | 0.91 | ACHE (0.36) | ACHEKCNH2CACNA1I | |
| SCHEMBL19959010 | 0.86 | CHRM5 (0.33) | ACHE | |
| SCHEMBL19959057 | 0.85 | KCNH2 (0.38) | KCNH2CACNA1I | |
| SCHEMBL19958993 | 0.85 | KCNH2 (0.38) | KCNH2CACNA1I | |
| SCHEMBL19959067 | 0.85 | KCNH2 (0.38) | KCNH2CACNA1I | |
| SCHEMBL20314521 | 0.80 | ACHE (0.33) | ACHE | |
| SCHEMBL19959065 | 0.79 | KCNH2 (0.42) | ACHEKCNH2CACNA1I | |
| SCHEMBL21934606 | 0.79 | CHRM5 (0.33) | ACHE | |
| SCHEMBL21933962 | 0.79 | CHRM5 (0.33) | ACHE | |
| SCHEMBL21933954 | 0.79 | CHRM5 (0.33) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180072711-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ARVINAS OPERATIONS, INC. | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072711-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ESR1, GPER1, ESR2 | ACHE 518/4885KCNH2 3892/4885CACNA1I 2783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.